7JLS image
Deposition Date 2020-07-30
Release Date 2021-06-09
Last Version Date 2024-05-22
Entry Detail
PDB ID:
7JLS
Title:
RV3666c bound to tripeptide
Biological Source:
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Probable periplasmic dipeptide-binding lipoprotein DppA
Gene (Uniprot):dppA
Chain IDs:A
Chain Length:553
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Polymer Type:polypeptide(L)
Molecule:Peptide SER-VAL-ALA
Chain IDs:B
Chain Length:3
Number of Molecules:1
Biological Source:Escherichia coli BL21(DE3)
Primary Citation
Biophysical analysis of the Mycobacteria tuberculosis peptide binding protein DppA reveals a stringent peptide binding pocket.
Tuberculosis (Edinb) 132 102157 102157 (2021)
PMID: 34894561 DOI: 10.1016/j.tube.2021.102157

Abstact

The peptide binding protein DppA is an ABC transporter found in prokaryotes that has the potential to be used as drug delivery tool for hybrid antibiotic compounds. Understanding the motifs and structures that bind to DppA is critical to the development of these bivalent compounds. This study focused on the biophysical analysis of the MtDppA from M. tuberculosis. Analysis of the crystal structure revealed a SVA tripeptide was co-crystallized with the protein. Further peptide analysis demonstrated MtDppA shows very little affinity for dipeptides but rather preferentially binds to peptides that are 3-4 amino acids in length. The structure-activity relationships (SAR) between MtDppA and tripeptides with varied amino acid substitutions were evaluated using thermal shift, SPR, and molecular dynamics simulations. Efforts to identify novel ligands for use as alternative scaffolds through the thermal shift screening of 35,000 compounds against MtDppA were unsuccessful, indicating that the MtDppA binding pocket is highly specialized for uptake of peptides. Future development of compounds that seek to utilize MtDppA as a drug delivery mechanism, will likely require a tri- or tetrapeptide component with a hydrophobic -non-acidic peptide sequence.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback